{"SLR NAME":"The use of invasive mechanical ventilation in COVID-19 patients: a systematic review","References":[{"title1":"Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients","References":[{"title2":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future","References":[{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"WHO. https://www.who.int/emergencies/diseases/novel-coronavirus-2019."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"Global transport networks and infectious disease spread"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"New SARS-like virus in China triggers alarm"},{"title3":"A decade after SARS: strategies for controlling emerging coronaviruses"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Molecular evolution of human coronavirus genomes"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures"},{"title3":"Modeling the spread of Middle East respiratory syndrome coronavirus in Saudi Arabia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"The effects of temperature and relative humidity on the viability of the SARS coronavirus"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Evidence for camel-to-human transmission of MERS Coronavirus"},{"title3":"The camel connection"},{"title3":"Chinese I. https://m.thepaper.cn/newsDetail_forward_5835114?from=groupmessage&amp;isappinstalled=0.2020."},{"title3":"Real-time reverse transcription-polymerase chain reaction assay for SARSassociated coronavirus"},{"title3":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method"},{"title3":"Pharmacologic treatment of SARS: current knowledge and recommendations"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Molecular dynamic simulations analysis of ritonavir and lopinavir as SARSCoV 3CL(pro) inhibitors"},{"title3":"Antiviral treatment guidelines for middle east respiratory syndrome"},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavirritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"}]},{"title2":"The reproductive number of COVID-19 is higher compared to SARS coronavirus","References":[{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China"},{"title3":"Transmission dynamics of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions"},{"title3":"Early transmissibility assessment of a novel coronavirus in Wuhan, China"},{"title3":"Estimating the effective reproduction number of the 2019-nCoV in China"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a datadriven analysis in the early phase of the outbreak"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019-nCoV"},{"title3":"Estimation of the transmission risk of 2019-nCov and its implication for public health interventions (January 24, 2020)"},{"title3":"Early transmission dynamics in wuhan, china, of novel coronavirus-infected pneumonia"}]},{"title2":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERSepidemic","References":[]},{"title2":"COVID-19: lessons from SARS and MERS","References":[]},{"title2":"A systematic review of lopinavir therapy for sars coronavirus and mers coronavirus-a possible reference for coronavirus disease-19 treatment option","References":[{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"  . Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en/. Accessed."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Lopinavir"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamics"},{"title3":"Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors"},{"title3":"Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Virology: SARS virus infection of cats and ferrets"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Old drugs for a new bug: influenza, HIV drugs enlisted to fight SARS"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers"},{"title3":"Antiviral treatment guidelines for Middle East respiratory syndrome"},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-beta1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial"},{"title3":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment"},{"title3":"Potential antiviral therapeutics for 2019 novel coronavirus"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Efficacies of lopinavir/ritonavir and abidol in the treatment of novel coronavirus pneumonia"}]},{"title2":"Expert recommendations for tracheal intubation in critically ill patients with noval coronavirusdisease 2019","References":[{"title3":"Announcement of the state health and Health Commission of the people's Republic of China[2010]01"},{"title3":"Diagnosis and Treatment Regimen of Novel Coronavirus Pneumonia (trial 6th edition). NHC Issue [2020]145"},{"title3":"Guideline of Prevention and Control of Novel Coronavirus Infection within Medical Facilities (first edition). NHC Issue [2020]65"},{"title3":"Guideline of the Application Range of Common Medical Protective Products in Prevention and control of Novel Coronavirus Pneumonia (trial edition). NHC Issue [2020]75"},{"title3":"Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"Guidelines and recommendations for perioperative infection control in patients with 2019 novel coronavirus"},{"title3":"Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway"},{"title3":"Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults"},{"title3":"Guideline for management of difficult airway (CSA 2017 edition)"},{"title3":"The use of extra-corporeal membrane oxygenation In the anticipated difficult airway: a case report and systematic review"},{"title3":"Anesthesia and SARS"}]},{"title2":"Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV","References":[{"title3":"Review of bats and SARS"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Molecular mechanisms of coronavirus RNA capping and methylation"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses:A statement of the Coronavirus Study Group"},{"title3":"WHO Named the New Pneumonia &quot;COVID-19&quot;"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"2015 MERS outbreak in Korea: Hospital-to-hospital transmission"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"The 2019 Novel Coronavirus Resource"},{"title3":"NCBI Database. 2019-nCoV"},{"title3":"GSAID Database. 2020 Coronavirus"},{"title3":"NCBI Blast"},{"title3":"Zpicture"},{"title3":"MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets"},{"title3":"Prospects for inferring very large phylogenies by using the neighbor-joining method"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"Weekly Epidemiological Record, 2013, vol. 88, 35 [full issue]"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Severe acute respiratory syndrome-Singapore, 2003"},{"title3":"Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003"},{"title3":"The SARS wake-up call"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"Epidemic Update and Risk Assessment of 2019 Novel Coronavirus"},{"title3":"Return of the Coronavirus: 2019-nCoV"},{"title3":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients"},{"title3":"Middle East respiratory syndrome: Emergence of a pathogenic human coronavirus"},{"title3":"Diagnosis and Treatment of Pneumonia Caused by 2019-nCoV (Trial Version 4)"},{"title3":"Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)"},{"title3":"Incubation periods of acute respiratory viral infections: A systematic review"},{"title3":"Multiple contact dates and SARS incubation periods"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"SARS: Epidemiology"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"The severe acute respiratory syndrome"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: An analysis of all 1755 patients"},{"title3":"Infectious Disease Expert Li Lanjuan Responded to Six Questions of 2019-nCoV"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"Press Conference of the National Health Commission of the People's Republic of China on 3 February 2020"},{"title3":"Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans"},{"title3":"Novel coronavirus: From discovery to clinical diagnostics"},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm"},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"South China Agricultural University: Pangolin May Be a Potential Intermediate Host of New Coronavirus"},{"title3":"Model parameters and outbreak control for SARS"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan"},{"title3":"Distribution of Pneumonia Infected by 2019-nCoV"},{"title3":"Real-time Updates of COVID-19 Epidemic in China"},{"title3":"The extent of transmission of novel coronavirus in Wuhan, China, 2020"},{"title3":"Potential of large 'first generation' human-to-human transmission of 2019-nCoV"},{"title3":"Novel Wuhan (2019-nCoV) Coronavirus"},{"title3":"The Role of Fecal-Oral Transmission in All transmission Still Need Further Observation and Research"},{"title3":"There Is No Evidence That the New Coronavirus Can Be Transmitted through Aerosol"},{"title3":"SARS transmission, risk factors, and prevention in Hong Kong"},{"title3":"Outbreak of Pneumonia of Unknown Etiology in Wuhan China: The Mystery and the Miracle"},{"title3":"Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003"},{"title3":"The Fight against the 2019-nCoV Outbreak: An Arduous March Has Just Begun"},{"title3":"SARS and MERS: Recent insights into emerging coronaviruses"},{"title3":"The First New Coronavirus Species Information Was Published by the National Pathogen Microorganism Resource Bank"},{"title3":"The utility of preemptive mass influenza vaccination in controlling a SARS outbreak during flu season"},{"title3":"Characterization of a New Member of Alphacoronavirus with Unique Genomic Features in Rhinolophus Bats"},{"title3":"Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Development and evaluation of novel real-time reverse transcription-PCR assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"National Medical Products Administration Examined and Approved the New Nucleic Acid Test Reagent of Coronavirus Again"},{"title3":"Emerging coronaviruses: Genome structure, replication, and pathogenesis"},{"title3":"Treatment of SARS with human interferons"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Explanation on the Situation that Drugs for AIDS Can Be Tried to Treat Pneumonia Caused by 2019-nCoV Infection"},{"title3":"The Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University Discovered a Batch of Old Drugs and Traditional Chinese Medicines with Therapeutic Potential for COVID-19"},{"title3":"High-Resolution Crystal Structure of 2019-nCoV Coronavirus 3CL Hydrolase (Mpro) was Announced by the Joint Research Team of Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and ShanghaiTech University"},{"title3":"Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"A randomized, controlled trial of Ebola virus disease therapeutics"},{"title3":"First Case of 2019 Novel Coronavirus in the United States"},{"title3":"Research progress on novel coronavirus (2019-nCoV) related drugs in vitro/vivo"},{"title3":"China-Japan Friendship Hospital: Clinical Experimental Research Work Is Being Carried Out on Remdesivir"},{"title3":"Recombination in large RNA viruses: Coronaviruses"},{"title3":"Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding"},{"title3":"SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes"},{"title3":"Jumping species:A mechanism for coronavirus persistence and survival"},{"title3":"Serological evidence of bat SARS-related coronavirus infection in humans, China"},{"title3":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike"},{"title3":"SARS: Clinical virology and pathogenesis"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Coronaviruses post-SARS: Update on replication and pathogenesis"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): A report from China"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways"},{"title3":"SARS: Clinical features and diagnosis"},{"title3":"Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS"},{"title3":"The Novel Chinese Coronavirus (2019-nCoV) Infections: Challenges for fighting the storm"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"MERS coronaviruses in dromedary camels, Egypt"}]},{"title2":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC)"},{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"MERS coronavirus outbreak: implications for emerging viral infections"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Helicobacter pylori multiplex serology"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"SARS: epidemiology"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Risks of death and severe disease in patients with Middle East Respiratory Syndrome Coronavirus, 2012-2015"},{"title3":"Estimating the risk of Middle East Respiratory Syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Transmission of 2019-nCoV Infection from an asymptomatic contact in Germany"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature"},{"title3":"MERS transmission and risk factors: a systematic review"},{"title3":"Severe Acute Respiratory Syndrome (SARS)-lessons for future pandemics"},{"title3":"Public Health Network Structure and Collaboration Effectiveness during the 2015 MERS outbreak in South Korea: an institutional collective action framework"},{"title3":"Leung Gm Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"CDC. CDC Advises Travelers to Avoid All Nonessential Travel to China. https://www.cdc.gov/media/releases/2020/s0128-travelers-avoid-china.html (2 April 2020, date last accessed)."}]},{"title2":"Asymptomatic novel coronavirus pneumonia patient outside Wuhan: the value of CT images in the course of the disease","References":[{"title3":"Locations with confirmed COVID-19 cases"},{"title3":"Coronavirus disease 2019 (COVID-19) situation report-25"},{"title3":"Coronavirus disease 2019 (COVID-19) in the U.S"},{"title3":"PubMed search on novel coronavirus pneumonia AND radiology"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing"},{"title3":"In defense of case reports and case series"}]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","References":[]},{"title2":"Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novelcoronavirus disease","References":[]},{"title2":"Precautions in ophthalmic practice in the prevention and control of the novel coronaviruspneumonia epidemic","References":[]},{"title2":"Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [e-pub ahead of print]. JAMA. https://doi.org/10.1001/jama.2020.1585, accessed February 7, 2020."},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [e-pub ahead of print]. J Med Virol. https://doi.org/10.1002/jmv.25702, accessed February 7, 2020."}]}]},{"title1":"Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)","References":[{"title2":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle","References":[{"title3":"XINHUANET News Report"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Coronaviruses-drug discovery and therapeutic options"},{"title3":"Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"}]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China","References":[{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Pneumonia in China: lack of information raises concerns among Hong Kong health workers"},{"title3":"Taking forward a' One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential"},{"title3":"ProMED &quot;Novel coronavirus - China (01): (HU) WHO, phylogenetic tree&quot;. Archive Number: 20200112.6885385. Accessed 13 Jan 2020. https://www.ecohealthalliance.org/2020/01/phylogenetic-analysis-shows-novel-wuhan-coronavirus-clusters-with-sars."}]},{"title2":"Coronavirus infections: more than just the common cold","References":[]},{"title2":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected","References":[]},{"title2":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","References":[{"title3":"Angiotensinconverting enzyme 2 is an essential regulator of heart function"},{"title3":"The role of ACE2 in cardiovascular physiology"},{"title3":"Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice"},{"title3":"Loss of angiotensinconverting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Deletion of angiotensinconverting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II"},{"title3":"Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"ACE2: from vasopeptidase to SARS virus receptor"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"The severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study"},{"title3":"Cardiovascular complications of severe acute respiratory syndrome"},{"title3":"Verapamil ameliorates the clinical and pathological course of murine myocarditis"},{"title3":"Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice"},{"title3":"Widespread myocardial inflammation and infarct-related artery patency"},{"title3":"Severe acute respiratory syndrome-associated coronavirus in lung tissue"},{"title3":"Pulmonary pathology of severe acute respiratory syndrome in Toronto"},{"title3":"A novel angiotensinconverting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Detection of SARS coronavirus in plasma by real-time RT-PCR"},{"title3":"Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells"},{"title3":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry"},{"title3":"Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2"},{"title3":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling"},{"title3":"Myocarditis: current trends in diagnosis and treatment"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)"},{"title3":"Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling"}]},{"title2":"A Novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","References":[{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"SWISSMODEL: an automated protein homology-modeling server"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"}]},{"title2":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia","References":[]},{"title2":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","References":[]}]},{"title1":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title2":"A novel coronavirus associated with severe acute respiratory syndrome","References":[{"title3":"Ahmadi KS, Vahabizad F, Banihashemi G, Sahraian MA,  Gheini MR, Eslami M, Marhamati H, Mirhadi MS (2020) Ischemic stroke in patients with COVID-19 disease: a report of 10 cases from Iran Cerebrovasc Dis 1-6 10.1159/000513279"},{"title3":"Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19"},{"title3":"COVID-19 infection recurrence presenting with meningoencephalitis"},{"title3":"Matos AR, Quintas-Neves M, Oliveira AI, Dias L, Marques S, Carvalho R, Alves JN (2020) COVID-19 associated central nervous system vasculopathy Can J Neurol Sci 1-6 10.1017/cjn.2020.1092020.1092020.1092020.109"},{"title3":"Focal cerebral arteriopathy in a COVID-19 pediatric patient"},{"title3":"An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19"},{"title3":"A first case of meningitis/encephalitis associated with SARS-Coronavirus-2"},{"title3":"COVID-19, SARS and MERS: a neurological perspective"},{"title3":"Frontier therapeutics and vaccine strategies for sars-cov-2 (COVID-19): a review"},{"title3":"A review of Coronavirus Disease-2019 (COVID-19)"},{"title3":"Neurological manifestations in severe acute respiratory syndrome"},{"title3":"Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses Brain Behav Immun 18-22 10.1016/j.bbi.2020.03.0312020.03.0312020.03.0312020.03.031"},{"title3":"Encephalitis as a clinical manifestation of COVID-19"},{"title3":"Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review"}]},{"title2":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome","References":[{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Children with respiratory disease associated with metapneumovirus in Hong Kong"},{"title3":"Phylogenetic analysis of a highly conserved region of the polymerase gene from 11 coronaviruses and development of a consensus polymerase chain reaction assay"},{"title3":"Characterization of human metapneumoviruses isolated from patients in North America"},{"title3":"Chan PKS, Tam JS, Lam CW, etal. Detection of human metapneumovirus from patients with severe acute respiratory syndrome: a methodological evaluation. Emerg Infect Dis (in press)."},{"title3":"Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene"},{"title3":"Detection of Chlamydia trachomatis in clinical specimens by the polymerase chain reaction"},{"title3":"Rapid and standardised detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR"},{"title3":"A newly discovered human metapneumovirus isolated from young children with respiratory tract disease"},{"title3":"Experimental infection of adult axenic rats with Parker's rat coronavirus"},{"title3":"Pathogenicity of experimental infection with 'pneumotropic' porcine coronavirus"},{"title3":"Pathogenicity of porcine respiratory coronavirus isolated in Quebec"},{"title3":"Measles virus and immunomodulation: molecular bases and perspectives"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV)","References":[]},{"title2":"Novel coronavirus - China","References":[]},{"title2":"Novel coronavirus - Thailand (ex-China)","References":[{"title3":"Life experiences and support perceived by nurses in hospital haemodialysis units during the COVID-19 pandemic in Spain"},{"title3":"Connecting with generation Z: Approaches in nursing education"},{"title3":"Qualitative descriptive methods in health science research"},{"title3":"The characteristic of generation Z"},{"title3":"Nurses at the front line of COVID-19: Roles, responsibilities, risks, and rights"},{"title3":"Implications for COVID-19: A systematic review of nurses' experiences of working in acute care hospital settings during a respiratory pandemic"},{"title3":"Exploring nurses' experiences of psychological distress during care of patients with COVID-19: A qualitative study"},{"title3":"Novice nurse's transitioning to emergency nurse during COVID-19 pandemic: A qualitative study"},{"title3":"Generation Z students: Will they change our nursing classrooms?"},{"title3":"Novice nurses' experiences of unpreparedness at the beginning of the work"},{"title3":"Frontline nurses' burnout, anxiety, depression, and fear statuses and their associated factors during the COVID-19 outbreak in Wuhan, China: A large-scale cross-sectional study"},{"title3":"New graduate nurses' experiences in a clinical specialty: A follow up study of newcomer perceptions of transitional support"},{"title3":"Experiences and psychosocial problems of nurses caring for patients diagnosed with COVID-19 in Turkey: A qualitative study"},{"title3":"Final clinical practicum, transition experience and turnover intentions among newly graduated nurses: A cross sectional study"},{"title3":"The impact of human resource development on organizational effectiveness: An empirical study"},{"title3":"The lived experience of nurses caring for patients with COVID-19 in Iran: A phenomenological study"},{"title3":"The experiences of health-care providers during the COVID-19 crisis in China: A qualitative study"},{"title3":"Experiences of nurses during the COVID-19 pandemic: A mixed-methods study"},{"title3":"Rapid deployment of critical care nurse education during the COVID-19 pandemic"},{"title3":"Effective orientation programs for new graduate nurses: A systematic review"},{"title3":"Exploring nursing managers' perceptions of nursing workforce management during the outbreak of COVID-19: A content analysis study"},{"title3":"Coronavirus infectious disease-2019 (COVID-19): A case report, the first patient in Thailand and outside China"},{"title3":"Nursing experiences of COVID-19 outbreak in Iran: A qualitative study"},{"title3":"Experiences of geriatric nurses in nursing home settings across four countries in the face of the COVID-19 pandemic"},{"title3":"Deciding about the use of a personal safety alerting device:The need for a legitimation process: A qualitative study"},{"title3":"Nurses on the frontline against the COVID-19 pandemic: An integrative review"},{"title3":"The impact of human resource development (HRD) practices on organizational effectiveness: A review"},{"title3":"Holistic care for patients with severe coronavirus disease 2019: An expert consensus"},{"title3":"The experience of transition from nursing students to newly graduated registered nurses in Singapore"},{"title3":"Nurses' psychological changes and coping strategies during home isolation for the 2019 novel coronavirus in China: A qualitative study"}]},{"title2":"Novel coronavirus - Japan (ex-China)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle"},{"title3":"WHO. WHO coronavirus (COVID-19) (2022) dashboard https://covid19.who.int/"},{"title3":"Early dynamics of transmission and control of COVID-19: A mathematical modelling study"},{"title3":"A review on COVID-19 forecasting models"},{"title3":"Predictive models of COVID-19 in India: A rapid review"},{"title3":"Forecasting the spread of COVID-19 under different reopening strategies"},{"title3":"A modified age-structured SIR model for COVID-19 type viruses"},{"title3":"Inefficiency of SIR models in forecasting COVID-19 epidemic: A case study of Isfahan"},{"title3":"Baek, J. et al. (2020) The limits to learning an sir process granular for COVID-19. Preprint at arXiv:2006.06373v1"},{"title3":"Quantifying the time-lag effects of human mobility on the COVID-19 transmission: A multi-city study in China"},{"title3":"The effect of population mobility on COVID-19 incidence in 314 Latin American cities: A longitudinal ecological study with mobile phone location data"},{"title3":"Changes in social environment due to the state of emergency and go to campaign during the COVID-19 pandemic in Japan: An ecological study"},{"title3":"The impact of declaring the state of emergency on human mobility during COVID-19 pandemic in Japan"},{"title3":"Mobility network models of COVID-19 explain inequities and inform reopening"},{"title3":"Commentary on Ferguson, et al., impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand"},{"title3":"Member of WIN and Gallup International Association. (2022) NR YouGov information https://www.nrc.co.jp/nryg/211227.html"},{"title3":"The &lt;Three Cs&gt; of Japan's pandemic response as an ideograph"},{"title3":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Agent-based modeling for super-spreading events: A case study of MERS-CoV transmission dynamics in the Republic of Korea"},{"title3":"Mobility change and COVID-19 in Japan: Mobile data analysis of locations of infection"},{"title3":"Non-compulsory measures sufficiently reduced human mobility in Tokyo during the COVID-19 epidemic"},{"title3":"Reduction in mobility and COVID-19 transmission"},{"title3":"The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak"},{"title3":"Shorter incubation period among unvaccinated delta variant coronavirus disease 2019 patients in Japan"},{"title3":"Shorter incubation period among COVID-19 cases with the BA.1 Omicron variant"},{"title3":"Association between mobility patterns and COVID-19 transmission in the USA: A mathematical modelling study"},{"title3":"The effect of human mobility and control measures on the COVID-19 epidemic in china"},{"title3":"Ogiwara, K. (2021) Coronavirus disease (COVID-19) situation report in Japan https://toyokeizai.net/sp/visual/tko/covid19/en.html"},{"title3":"Tokyo Metropolitan Government. (2020) Number of Ovid-19 positive cases by date of onset https://stopcovid19.metro.tokyo.lg.jp/cards/positive-number-by-developed-date/"},{"title3":"Number of subscribers by carriers. (2021) Webpage in Japanese. Telecommunications Carriers Association. https://www.tca.or.jp/database/"},{"title3":"A contribution to the mathematical theory of epidemics"},{"title3":"The approximately universal shapes of epidemic curves in the Susceptible-Exposed-Infectious-Recovered (SEIR) model"},{"title3":"Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions"},{"title3":"A cluster analysis method for grouping means in the analysis of variance"},{"title3":"Geometric interpretation of gene coexpression network analysis"},{"title3":"Phylogenetic network analysis of SARS-CoV-2 genomes"},{"title3":"Topological dynamics of the 2015 South Korea MERS-CoV spread-on-contact networks"},{"title3":"Toyo Keizai Online The novel coronavirus diseaseDisease (COVID-19) Situation Report in Japan. https://toyokeizai.net/sp/visual/tko/covid19/en.html."}]},{"title2":"Novel coronavirus - Republic of Korea (ex-China)","References":[{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents"},{"title3":"Early Epidemiological and Clinical Characteristics of 28 cases of Coronavirus Disease in South Korea"},{"title3":"Coronavirus Disease-19: Summary of 2,370 contact investigations of the first 30 cases in the Republic of Korea"},{"title3":"Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards"},{"title3":"Environmental Contamination and Viral Shedding in MERS Patients during MERS-CoV Outbreak in South Korea"},{"title3":"Airflow as a possible transmission route of Middle East respiratory syndrome at an initial outbreak hospital in Korea"},{"title3":"Airflow analysis of Pyeongtaek St. Mary's hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"title3":"Identification of coronavirus isolated from a patient in Korea with COVID-19"},{"title3":"A lesson from temporary closing of a single university-affiliated hospital owing to in-hospital transmission of coronavirus disease 2019"},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient"}]},{"title2":"First travel-related case of 2019 novel coronavirus detected in United States","References":[]},{"title2":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020","References":[{"title3":"From &quot;A&quot;IV to &quot;Z&quot;IKV: attacks from emerging and Re-emerging  pathogens"},{"title3":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability"},{"title3":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood"}]},{"title2":"Relationship between the presence of hypoxemia and the inflammatory response measured by C-reactive protein in bacteremic pneumococcal pneumonia","References":[]},{"title2":"KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"CDC definitions for nosocomial infections, 1988","References":[]},{"title2":"Association between cardiac injury and mortality in hospitalized patients infected with avian influenza A (H7N9) virus","References":[{"title3":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series."},{"title3":"The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019."},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection."},{"title3":"Clinicopathologic study of thirty-three fatal cases of Asian influenza."},{"title3":"Observations on the A2 England influenza epidemic: A clinicopathological study."},{"title3":"Echocardiographic manifestations of pandemic 2009 (H1N1) influenza a virus infection."},{"title3":"2009 pandemic H1N1-associated myocarditis in a previously healthy adult."},{"title3":"Influenza myocarditis and myositis: Case presentation and review of the literature."},{"title3":"Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care."},{"title3":"Cardiac complications of influenza infection in 3 adults."},{"title3":"Acute myocardial infarction after laboratory-confirmed influenza infection."},{"title3":"Cardiac complications associated with the influenza viruses A subtype H7N9 or pandemic H1N1 in critically ill patients under intensive care."},{"title3":"Influenza, autoimmunity and atherogenesis."},{"title3":"Cardiovascular manifestations associated with influenza virus infection."},{"title3":"The cardiovascular manifestations of influenza: a systematic review."},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection."},{"title3":"Epidemiology of human infections with avian influenza A(H7N9) virus in China."},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review."},{"title3":"Fourth Universal Definition of Myocardial Infarction (2018)."},{"title3":"The prevalence and findings of subclinical influenza-associated cardiac abnormalities among Japanese patients."},{"title3":"Accuracy of Doppler-echocardiographic mean pulmonary artery pressure for diagnosis of pulmonary hypertension."},{"title3":"Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography."},{"title3":"2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"KDIGO clinical practice guidelines for acute kidney injury."},{"title3":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis."},{"title3":"Adjuvant corticosteroid treatment in adults with influenza a (H7N9) viral pneumonia."},{"title3":"A case of influenza type a myocarditis that presents with ST elevation MI, cardiogenic shock, acute renal failure, and rhabdomyolysis and with rapid recovery after treatment with oseltamivir and intra-aortic balloon pump support."},{"title3":"Acute cardiac injury events &lt;=30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012."},{"title3":"Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: A randomized controlled trial."},{"title3":"Transient cardiac injury during H7N9 infection."},{"title3":"Relation of concomitant heart failure to outcomes in patients hospitalized with influenza."},{"title3":"Extreme influenza epidemics and out-of-hospital cardiac arrest."},{"title3":"Experimental influenza A virus myocarditis in mice. Light and electron microscopic, virologic, and hemodynamic study."},{"title3":"The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis."},{"title3":"Overexpression of tumor necrosis factor (TNF)alpha and TNFalpha receptor I in human viral myocarditis: clinicopathologic correlations."},{"title3":"Fulminant myopericarditis in an immunocompetent adult due to pandemic 2009 (H1N1) influenza A virus infection."},{"title3":"The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection."},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia."},{"title3":"Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09."},{"title3":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG."},{"title3":"The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: Results of two international observational cohort studies."},{"title3":"Myocardial dysfunction in severe sepsis and septic shock: More questions than answers?"},{"title3":"Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction."},{"title3":"Acute infection and myocardial infarction."},{"title3":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection."},{"title3":"Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?"}]},{"title2":"Coronaviruses post-SARS: update on replication and pathogenesis","References":[{"title3":"Severe acute respiratory syndrome"},{"title3":"Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion"},{"title3":"Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy"},{"title3":"The molecular biology of coronaviruses"},{"title3":"Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro"},{"title3":"Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4alpha"},{"title3":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling"},{"title3":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo"},{"title3":"The small envelope protein E is not essential for murine coronavirus replication"},{"title3":"Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway"},{"title3":"Viroporin activity of murine hepatitis virus E protein"},{"title3":"SARS coronavirus E protein forms cation-selective ion channels"},{"title3":"Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice"},{"title3":"Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS"},{"title3":"The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication"},{"title3":"Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells"},{"title3":"Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein"},{"title3":"The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles"},{"title3":"Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3"},{"title3":"A contemporary view of coronavirus transcription"},{"title3":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs"},{"title3":"Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer"},{"title3":"Nuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold"},{"title3":"Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs"},{"title3":"Crystal structure of a monomeric form of severe acute respiratory syndrome coronavirus endonuclease nsp15 suggests a role for hexamerization as an allosteric switch"},{"title3":"Structural genomics of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance structure of the protein nsP7"},{"title3":"Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3"},{"title3":"Novel beta -barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus"},{"title3":"Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus"},{"title3":"Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family"},{"title3":"Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme"},{"title3":"Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murine hepatitis virus strain A59 replication"},{"title3":"The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world"},{"title3":"Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis"},{"title3":"High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants"},{"title3":"Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. USA 10 Feb 2009 (doi:10.1073/pnas.0808790106)."},{"title3":"Major genetic marker of nidoviruses encodes a replicative endoribonuclease"},{"title3":"Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"Molecular interactions in the assembly of coronaviruses"},{"title3":"Coronavirus replication complex formation utilizes components of cellular autophagy"},{"title3":"Coronavirus replication does not require the autophagy gene ATG5"},{"title3":"Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex"},{"title3":"Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles"},{"title3":"Membrane topology of murine coronavirus replicase nonstructural protein 3"},{"title3":"Topology and membrane anchoring of the coronavirus replication complex: Not all hydrophobic domains of nsp3 and nsp6 are membrane spanning"},{"title3":"Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replication"},{"title3":"A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection"},{"title3":"Multiple organ infection and the pathogenesis of SARS. J"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Identification of a new human coronavirus"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Mosaic structure of human coronavirus NL63, one thousand years of evolution"},{"title3":"Croup is associated with the novel coronavirus NL63"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein"},{"title3":"Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease"},{"title3":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus"},{"title3":"Identification of a novel coronavirus in bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Bovine-like coronaviruses isolated from four species of captive wild ruminants are homologous to bovine coronaviruses based on complete genomic sequences"},{"title3":"Analysis of the genome sequence of an alpaca coronavirus"},{"title3":"Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein"},{"title3":"Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features"},{"title3":"Detection of group 1 coronaviruses in bats in North America"},{"title3":"Detection and prevalence patterns of group I coronaviruses in bats, northern Germany"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Comparative analysis of complete genome sequences of three novel avian coronaviruses reveals a novel group 3c coronavirus"},{"title3":"Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China"},{"title3":"Identification of a novel coronavirus from a beluga whale by using a panviral microarray"},{"title3":"Immunopathogenesis of coronavirus infections: implications for SARS"},{"title3":"Coronavirus infection of the central nervous system: host-virus stand-off"},{"title3":"Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis"},{"title3":"Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus"},{"title3":"Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus"},{"title3":"Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells"},{"title3":"Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"A mouse-adapted SARS-Coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition"},{"title3":"Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by double-stranded RNA"},{"title3":"Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3"},{"title3":"Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein"},{"title3":"SARS coronavirus proteins Orf 3b, Orf 6, and nucleocapsid function as interferon antagonists"},{"title3":"Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism"},{"title3":"Severe acute respiratory syndrome-CoV protein 6 is required for optimal replication"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Differential regulation of innate and adaptive immune responses in viral encephalitis"},{"title3":"Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells"},{"title3":"Control of coronavirus infection through plasmacytoid dendritic cell-derived type I interferon"},{"title3":"Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia"},{"title3":"Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"The immunobiology of SARS"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Lethal infection in K18-hACE2 mice infected with SARS-CoV"},{"title3":"SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study"},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus"},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques"},{"title3":"Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus"},{"title3":"Establishment of &quot;The Gene Mine&quot;: a resource for rapid identification of complex trait genes"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"RNA replication of mouse hepatitis virus takes place at double-membrane vesicles"},{"title3":"Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes"}]},{"title2":"A major outbreak of severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","References":[{"title3":"Severe respiratory illness associated with a novel coronavirus: Saudi Arabia and Qatar, 2012"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Global alert and response (GAR): novel coronavirus summary and literature update"},{"title3":"Global alert and response (GAR): novel coronavirus infection:update (Middle East respiratory syndrome coronavirus)"},{"title3":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV):worldwide, 2012-2013"},{"title3":"Rapid risk assessment: update:severe respiratory disease associated with a novel coronavirus"},{"title3":"Epidemiological update: additional confirmed cases of Middle East respiratory syndrome coronavirus (novel coronavirus) in France, Saudi Arabia, and Tunisia"},{"title3":"Table: confirmed cases of Middle East coronavirus infection reported in Europe (n=11 of 53 cases reported worldwide)"},{"title3":"Recovery from severe novel coronavirus infection"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013"},{"title3":"First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Prevalence of diabetes mellitus in a Saudi community"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Severe acute respiratory syndrome and coronavirus"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical and laboratory features in the early stage of severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Features discriminating SARS from other severe viral respiratory tract infections"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Assessing the pandemic potential of MERS-CoV"},{"title3":"Transmission scenarios for Middle East respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak"},{"title3":"Rapid diagnostics urgently needed for killer infections"},{"title3":"Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012"}]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]},{"title2":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","References":[{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"MERS-CoV: where are we now?"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry"},{"title3":"Emerging respiratory viral infections: MERS-CoV and influenza"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Middle East respiratory syndrome coronavirus &quot;MERS-CoV&quot;: current knowledge gaps"},{"title3":"2015 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) nosocomial outbreak in South Korea: insights from modeling"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"The epidemiology of MERS-CoV"},{"title3":"Emerging viral respiratory tract infections-environmental risk factors and transmission"},{"title3":"Dromedary camels and the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"},{"title3":"A. Mailles, K. Blanckaert, P. Chaud, S. van der Werf, B. Lina, V. Caro, et al., First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin 18 (2013)."},{"title3":"J. Premila Devi, W. Noraini, R. Norhayati, C. Chee Kheong, A.S. Badrul, S. Zainah, et al., Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 19 (2014)."},{"title3":"Tracing airline travelers for a public health investigation: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, 2014"},{"title3":"T. Briese, N. Mishra, K. Jain, I.S. Zalmout, O.J. Jabado, W.B. Karesh, et al., Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia, mBio 5 (2014) e01146-e01214."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction"},{"title3":"MERS-CoV geography and ecology in the Middle East: analyses of reported camel exposures and a preliminary risk map"},{"title3":"Dromedary MERS-CoV replicates in human respiratory tissues"},{"title3":"Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"Infection control and MERS-CoV in health-care workers"},{"title3":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East Respiratory Syndrome-Coronavirus from the central MERS-CoV designated hospital"},{"title3":"Acute management and long-term survival among subjects with severe Middle East Respiratory Syndrome coronavirus Pneumonia and Ards"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: demographic, clinical and survival data"},{"title3":"Guidelines for the laboratory diagnosis of Middle East respiratory syndrome coronavirus in Korea"},{"title3":"Cytometric bead array: a multiplexed assay platform with applications in various areas of biology"},{"title3":"Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts)"},{"title3":"Safety, tolerability, and immunogenicity of interferons"},{"title3":"A tale of two cytokines: IL-17 and IL-22 in asthma and infection"},{"title3":"Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis"},{"title3":"Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions"},{"title3":"Infection-induced IL-10 and JAK-STAT: a review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes"},{"title3":"MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Virus multiplicity of infection affects type I interferon subtype induction profiles and interferon-stimulated genes"},{"title3":"Interferon-stimulated genes response in endothelial cells following Hantaan virus infection"},{"title3":"Type I interferon induced epigenetic regulation of macrophages suppresses innate and adaptive immunity in acute respiratory viral infection"},{"title3":"T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates"},{"title3":"Coronavirus virulence genes with main focus on SARS-CoV envelope gene"},{"title3":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells"},{"title3":"L. Josset, V.D. Menachery, L.E. Gralinski, S. Agnihothram, P. Sova, V.S. Carter, et al., Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus, mBio 4 (2013) e00165-e00213."},{"title3":"IL-17 cytokines in immunity and inflammation"},{"title3":"IL-10, T cell exhaustion and viral persistence"},{"title3":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction"},{"title3":"The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes"},{"title3":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins"},{"title3":"Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function"},{"title3":"Hepatitis C virus targets the interferon-alpha JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes"},{"title3":"Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling"},{"title3":"Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells"},{"title3":"IL-15-PI3K-AKT-mTOR: a critical pathway in the life journey of natural killer cells"},{"title3":"TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals"},{"title3":"The IL-12 family of cytokines in infection, inflammation and autoimmune disorders"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Stimulation of IRF-7 gene expression by tumor necrosis factor alpha requirement for NFkappaB transcription factor and gene accessibility"}]},{"title2":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"  : Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34. http://www.who.int/csr/don/2003_04_02b/en/index.html."},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids"},{"title3":"Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype"},{"title3":"Macrophages in inflammation"},{"title3":"TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells"},{"title3":"Science review: apoptosis in acute lung injury"},{"title3":"Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)"},{"title3":"Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?"},{"title3":"C-reactive protein as a marker for inflammatory bowel disease"},{"title3":"The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells"},{"title3":"p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome"},{"title3":"The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor"},{"title3":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys"},{"title3":"HIV: prevention of opportunistic infections"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Drugs selectively blocking proinflammatory cytokines and cell receptors"},{"title3":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1:a review"}]},{"title2":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","References":[{"title3":"SARS coronavirus and innate immunity"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Viruses and interferon: a fight for supremacy"},{"title3":"MDA5/RIG-I and virus recognition"},{"title3":"Beyond pattern recognition: five immune checkpoints for scaling the microbial threat"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses"},{"title3":"NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections"},{"title3":"A weak signal for strong responses: interferon-alpha/beta revisited"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Innate immune response to viral infection of the lungs"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"SARS Immunity and Vaccination"},{"title3":"Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome"},{"title3":"Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus"},{"title3":"Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis"},{"title3":"Th17 cell based vaccines in mucosal immunity"},{"title3":"IL-10 family of cytokines"},{"title3":"Ysebrant de Lendonck L, Tonon S, Nguyen M, Vandevenne P, Welsby I, . (2013) Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes. Proc Natl Acad Sci USA. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;id=23918362&amp;retmode=ref&amp;cmd=prlinks."},{"title3":"IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages"},{"title3":"Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA (2013) Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis: 1-7. doi:10.1016/j.ijid.2013.07.002."}]},{"title2":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","References":[{"title3":"Anonymous. MERS-COV - Eastern Mediterranean (65) Saudi Arabia, RFI, Qatar. ProMED 20130904.1919328 (2013)."},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"de Wit, E. et al. Novel human betacoronavirus causes a transient lower respiratory tract infection in a rhesus macaque model. Proc. Natl. Acad. Sci. USA (in the press)."},{"title3":"Centers for Disease Control and Prevention (CDC). Update: Severe respiratory illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-worldwide, 2012-2013. MMWR Morb. Mortal. Wkly. Rep.62, 480-483 (2013)."},{"title3":"A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Pentaglobin in steroid-resistant severe acute respiratory syndrome"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models"},{"title3":"Interferon signaling and treatment outcome in chronic hepatitis C"},{"title3":"Branch mode selection during early lung development"},{"title3":"Expression of SHH signaling pathway components in the developing human lung"},{"title3":"Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways"},{"title3":"Hedgehog signaling in neonatal and adult lung"},{"title3":"FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network"},{"title3":"FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains"},{"title3":"The hedgehog system machinery controls transforming growth factor-beta-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis"},{"title3":"Oxidative damage and TGF-beta differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease"},{"title3":"Activation of the sonic hedgehog signaling controls human pulmonary arterial smooth muscle cell proliferation in response to hypoxia"},{"title3":"Protection from lipopolysaccharide-induced pulmonary microvascular endothelial cell injury by activation of hedgehog signaling pathway"},{"title3":"Key developmental regulators change during hyperoxia-induced injury and recovery in adult mouse lung"},{"title3":"Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill.18, 20427 (2013)."},{"title3":"Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis)"},{"title3":"Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus"},{"title3":"Normalization using weighted negative second order exponential error functions (NeONORM) provides robustness against asymmetries in comparative transcriptome profiles and avoids false calls"},{"title3":"Improving the efficiency of multidimensional scaling in the analysis of high-dimensional data using singular value decomposition"}]},{"title2":"SARS: systematic review of treatment effects","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":" . WHO coronavirus disease (COVID-19) dashboard. World Health Orgamization; 2021."},{"title3":"The artificial-liver blood-purification system can effectively improve hypercytokinemia for COVID-19"},{"title3":"A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"The Serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"The many faces of cytokine release syndrome-related coagulopathy"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report"},{"title3":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study"},{"title3":"Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19"},{"title3":"Thrombotic microangiopathies"},{"title3":"Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia"},{"title3":"Plasma exchange as rescue therapy in multiple organ failure including acute renal failure"},{"title3":"Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19"},{"title3":"Covid-19 vaccine passports: access, equity, and ethics"},{"title3":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and eExplanation"},{"title3":"Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)"},{"title3":"Plasma exchange for COVID-19 thrombo-inflammatory disease"},{"title3":"Plasma exchange: an effective rescue therapy in critically ill patients with coronavirus disease 2019 infection"},{"title3":"Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)"},{"title3":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients"},{"title3":"Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19"},{"title3":"Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm"},{"title3":"Plasma exchange in critically ill COVID-19 patients"},{"title3":"Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry"},{"title3":"A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report"},{"title3":"Application of plasma exchange in association with higher dose CVVH in cytokine storm complicating COVID-19"},{"title3":"Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19"},{"title3":"Continuous extracorporeal treatments in a dialysis patient with COVID-19"},{"title3":"Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19"},{"title3":"Hemoperfusion as a supportive treatment in a COVID-19 patient with late pulmonary thromboembolism: a case report"},{"title3":"Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS-CoV2 pneumonia"},{"title3":"Plasma exchange in the treatment of thrombotic microangiopathy associated with COVID-19 infection: a case report"},{"title3":"Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series"},{"title3":"Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID-19"},{"title3":"Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19"}]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings","References":[]},{"title2":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial","References":[{"title3":"World Health Organization: Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/. Accessed 14 Jan 2018."},{"title3":"Middle East Respiratory Syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A review of treatment modalities for Middle East Respiratory Syndrome"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis"},{"title3":"Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study"},{"title3":"Interferon beta-1b (betaseron/betaferon) is well tolerated at a dose of 500 microg: interferon dose escalation assessment of safety (IDEAS)"},{"title3":"Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Abbott Laboratories. Product Information: Kaletra . https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021226s030lbl.pdf. Accessed 14 Jan 2018."},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"SPIRIT 2013 statement: defining standard protocol items for clinical trials"},{"title3":"Chang, M. Adaptive Design Theory and implementation using SAS and R, 2nd ed. Chapman and Hall/CRC. 2014. Pp. 153-180."},{"title3":"Acute renal failure:definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer TM, 39, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17(39)."},{"title3":"Classification of acute pancreatitis:2012: revision of the Atlanta classification and definitions by international consensus"},{"title3":"Evaluating cancer patients for rehabilitation potential"},{"title3":"U.S. National Library of Medicine. LiverTox. https://livertox.nlm.nih.gov//Lopinavir.htm. Accessed 14 Jan 2018."},{"title3":"Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients"},{"title3":"Uniform requirements for manuscripts submitted to biomedical journals"},{"title3":"PubMed-cited research articles on the Middle East respiratory syndrome"},{"title3":"Non-randomised Ebola trials:lessons for optimal outbreak research"},{"title3":"Conducting research in disease outbreaks"},{"title3":"Modification of the sample-size and the schedule of interim analyses in survival trials based on data inspections"}]},{"title2":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","References":[{"title3":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"MERS-CoV Antibodies in Humans, Africa, 2013-2014"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides"},{"title3":"Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"New Metrics for Evaluating Viral Respiratory Pathogenesis"},{"title3":"A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients"},{"title3":"Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance"},{"title3":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China"},{"title3":"Viral Load Kinetics of MERS Coronavirus Infection"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication"},{"title3":"Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin"},{"title3":"Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Late Ebola virus relapse causing meningoencephalitis: a case report"}]},{"title2":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","References":[{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"Dudas, G., Carvalho, L. M., Rambaut, A. &amp; Bedford, T. MERS-CoV spillover at the camel-human interface. eLife7, e31257 (2018)."},{"title3":"Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis"},{"title3":"WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en/ (2018)."},{"title3":"MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study"},{"title3":"Kaletra. Highlights of Prescribing Information. https://www.rxabbvie.com/pdf/kaletratabpi.pdf (2017)."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"Arabi, Y. M. Twitter account for MIRACLE Trial. (2019)."},{"title3":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase"},{"title3":"Tchesnokov, E. P., Feng, J. Y., Porter, D. P. &amp; Gotte, M. Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses11, 326 (2019)."},{"title3":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors"},{"title3":"Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease"},{"title3":"Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain"},{"title3":"An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals"},{"title3":"Arabi, Y. M. MERS-CoV infection treated with a combination of lopinavir/ritonavir and interferon beta-1b (MIRACLE). https://clinicaltrials.gov/ct2/show/NCT02845843 (2016)."},{"title3":"New metrics for evaluating viral respiratory pathogenesis"},{"title3":"Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection"},{"title3":"Lossi, L., Castagna, C. &amp; Merighi, A. Caspase-3 mediated cell death in the normal development of the mammalian cerebellum. Int. J. Mol. Sci.19, 3999 (2018)."},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"Coronaviruses:drug discovery and therapeutic options"},{"title3":"Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy"},{"title3":"Clinical uses of interferons"},{"title3":"Virus interference. I. The interferon"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection"},{"title3":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment"},{"title3":"Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness"},{"title3":"The Superiority of IFN-lambda as a therapeutic candidate to control acute influenza viral lung infection"},{"title3":"Mouse models of acute respiratory distress syndrome: a review of analytical approaches, pathologic features, and common measurements"},{"title3":"National Institute of Allergy and Infectious Diseases (NIAID). Center, N.I.o.H.C. Investigational Therapeutics for the Treatment of People With Ebola Virus Disease NCT03719586. https://clinicaltrials.gov/ct2/show/NCT03719586?term=NCT03719586&amp;draw=2&amp;rank=1 (2019)."},{"title3":"National Institute of Allergy and Infectious Diseases (NIAID). Center, N.I.o.H.C. GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen NCT02818582. https://clinicaltrials.gov/ct2/show/NCT02818582?term=NCT02818582&amp;draw=2&amp;rank=1 (2019)."},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets"},{"title3":"Agostini, M. L. et al. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio9, e00221-18(2018)."},{"title3":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus"},{"title3":"Betaseron. Highlights of Prescribing Information. https://labeling.bayerhealthcare.com/html/products/pi/Betaseron_PI.pdf (2015)."},{"title3":"A simple practice guide for dose conversion between animals and human"},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method"}]},{"title2":"Origin and evolution of pathogenic coronaviruses","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Severe Acute Respiratory Syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"SARS-CoV-2 and COVID-19: the most important research questions"},{"title3":"New insights into the mechanisms of RNA recombination"},{"title3":"Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure"},{"title3":"RNA recombination in animal and plant viruses"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Adaptive evolution of MERS-CoV to species variation in DPP4"},{"title3":"Bats and coronaviruses"}]},{"title2":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Coronaviruses in bats from Mexico"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Host range, prevalence, and genetic diversity of adenoviruses in bats"},{"title3":"Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray"},{"title3":"Evolutionary relationships between bat coronaviruses and their hosts"},{"title3":"Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"RDP3: a flexible and fast computer program for analyzing recombination"},{"title3":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events"},{"title3":"Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in bats, Saudi Arabia"},{"title3":"Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?"},{"title3":"Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa"},{"title3":"Prediction and prevention of the next pandemic zoonosis"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry"}]},{"title2":"Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting","References":[{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"First isolation and characterization of bat SARS-like coronaviruses that use the ACE2 receptor"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Receptor recognition and cross-species infections of SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"SARS-CoV infection in a restaurant from palm civet"}]}]},{"title1":"Covid-19 in Critically Ill Patients in the Seattle Region  Case Series","References":[{"title2":"Novel coronavirus : China","References":[]},{"title2":"Coronavirus COVID-19 global cases","References":[{"title3":"ThWorld Health Organization Declares COVID-19 a 'Pandemic.' Here's What That Means"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Daily Report by Baidu"},{"title3":"Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea"},{"title3":"False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence"},{"title3":"A Systematic Review of COVID-19 Epidemiology Based on Current Evidence"},{"title3":"Contributions to the mathematical theory of epidemics:I"},{"title3":"Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak"},{"title3":"European Centre for Disease Prevention and Control"},{"title3":"Wikipedia (English) &quot;COVID-19 Testing&quot;"},{"title3":"Greedy Function Approximation: A Gradient Boosting Machine"},{"title3":"Scikit-learn: Machine Learning in Python"},{"title3":"Scikit-Learn"},{"title3":"Python Software Foundation"},{"title3":"Average Detection Rate of SARS-CoV-2 Infections is Estimated around Six Percent"},{"title3":"On the origin and continuing evolution of SARS-CoV-2"},{"title3":"CCR5Delta32 mutation and HIV infection: Basis for curative HIV therapy"},{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"X chromosome gene expression in human tissues: Male and female comparisons"},{"title3":"The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk: A meta-analysis involving 14,122 patients"},{"title3":"The ACE2 G8790A Polymorphism: Involvement in Type 2 Diabetes Mellitus Combined with Cerebral Stroke"},{"title3":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance"},{"title3":"The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients"},{"title3":"Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients"},{"title3":"SNPedia: A wiki supporting personal genome annotation, interpretation and analysis"},{"title3":"The BCG World Atlas: A database of global BCG vaccination policies and practices"},{"title3":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity"},{"title3":"Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis"}]},{"title2":"First case of 2019 novel coronavirus in the United States.","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"2019 Novel coronavirus outbreak (COVID-19)","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30]"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure"},{"title3":"Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J (2020) Chest CT for typical 2019nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 10.1148/radiol.2020200343"},{"title3":"Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion"},{"title3":"Chest computed tomography and lung ultrasound findings in COVID-19 pneumonia: a pocket review for non-radiologists"},{"title3":"Lung ultrasound may support diagnosis and monitoring of COVID-19 pneumonia"},{"title3":"Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study"},{"title3":"Performance of radiologists in differentiating COVID-19 from non-COVID-19 viral pneumonia at chest CT"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Is there a role for lung ultrasound during the COVID-19 pandemic"},{"title3":"Thoracic ultrasonography: a narrative review"},{"title3":"Proposal for international standardization of the use of lung ultrasound for patients with COVID-19: a simple, quantitative, reproducible method"},{"title3":"Detection of SARS-coV-2 in different types of clinical specimens"},{"title3":"On Lung Ultrasound patterns specificity in the management of COVID-19 patients"},{"title3":"Point-of-care lung ultrasound in patients with COVID-19:a narrative review"},{"title3":"DGRT n. 669 del 18-06-2018. Allegato A &quot;Modello organizzativo dell'Emergenza Pediatrica Ospedaliera. Linee di indirizzo.&quot; (2018) http://www.quotidianosanita.it/allegati/allegato3489968.pdf"},{"title3":"DGRT n.1380/2016 &quot;Reti cliniche tempo-dipendenti di cui al D.M. 70/2015. Approvazione documenti di programmazione delle reti regionali.&quot; Allegato C. (2016) https://www.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5135888&amp;nomeFile=Delibera_n.1380_del_27-12-2016-Allegato-C"},{"title3":"World Health Organization (2020) Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance. 20 March 2020. WHO/2019-nCoV/SurveillanceGuidance/2020.6"},{"title3":"World Health Organization (2020) Laboratory testing of human suspected cases of novel coronavirus (nCOV) infection: interim guidance January 12, 2020. https://apps.who.int/iris/bitstream/handle/10665/330374/WHO-2019-nCoV-laboratory-2020.1-eng.pdf"},{"title3":"Ministero della Salute (2016) Ministero della Salute:Assistenza, ospedale e territorio:118 e Pronto Soccorso:I codici colore gravita (triage). Ref type: online source"},{"title3":"Updated Manchester triage system published this month"},{"title3":"Accademia di Ecografia Toracica:Pleural Hubbers Team (2019) COVID-19 MANAGEMENT poster. https://www.ordine-medici-firenze.it/modulistica-docman/varie/311-adet/file. Ref type: online source"},{"title3":"World Health Organization (2020) Clinical management of COVID-19. Interim guidance 27 May 2020. WHO/2019-nCoV/clinical/2020.5"},{"title3":"CT imaging features of novel coronavirus (2019-nCoV)"},{"title3":"Societa Italiana di Emergenza Urgenza (SIMEU) (2019) Rapporto Prima Linea COVID-19_ecografia. https://www.simeu.it/w/articoli/leggiArticolo/4031/leggi. Ref type: online source"},{"title3":"http://www301.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5247300&amp;nomeFile=Ordinanza_del_Presidente_n.14_del_17-03-2020-Allegato-A (2020). Ref type: online source"},{"title3":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal"}]},{"title2":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response.","References":[]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State.","References":[]},{"title2":"Priorities for the US health community responding to COVID-19.","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition.","References":[]},{"title2":"Coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.","References":[{"title3":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. Available from: https://www.who.int/health-topics/coronavirus "},{"title3":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological. [Accessed 21 Jan 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319 "},{"title3":"de Groot RJ, Baker SC, Baric R, Enjuanes L, Gorbalenya AE, Holmes KV, et al. Family Coronaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. London; Waltham: Academic Press; 2012. p. 806-20."},{"title3":"The severe acute respiratory syndrome."},{"title3":"World Health Organization. (WHO. Novel Coronavirus (2019-nCoV). Situation report - 1. Geneva: WHO; 21 Jan 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf "},{"title3":"SARS testing: First past the post."},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China."},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction."},{"title3":"Coordinated implementation of chikungunya virus reverse transcription-PCR."},{"title3":"Assay optimization for molecular detection of Zika virus."},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences."},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission."},{"title3":"Hosts and sources of endemic human coronaviruses."},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS."},{"title3":"Origin and evolution of pathogenic coronaviruses."},{"title3":"The European Virus Archive goes global: A growing resource for research."},{"title3":"Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data."},{"title3":"Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018."},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV."},{"title3":"Advancing preparedness for clinical research during infectious disease epidemics."}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Early neuromuscular blockade in the acute respiratory distress syndrome.","References":[{"title3":"Incidence and mortality of acute respiratory distress syndrome in children: a systematic review and meta-analysis"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Ventilator-induced lung injury: from the bench to the bedside"},{"title3":"Ventilator-associated lung injury"},{"title3":"Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials"},{"title3":"Early hepatic dysfunction is associated with a worse outcome in patients presenting with acute respiratory distress syndrome: a post-hoc analysis of the ACURASYS and PROSEVA studies"},{"title3":"Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome"},{"title3":"Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome"},{"title3":"Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome"},{"title3":"Short-term effects of neuromuscular blockade on global and regional lung mechanics, oxygenation and ventilation in pediatric acute hypoxemic respiratory failure"},{"title3":"Early use of adjunctive therapies for pediatric acute respiratory distress syndrome: a PARDIE study"},{"title3":"Acute lung injury in children: therapeutic practice and feasibility of international clinical trials"},{"title3":"Mechanical ventilation strategies in children with acute lung injury: a survey on stated practice pattern*"},{"title3":"Nonpulmonary treatments for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference"},{"title3":"Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC)"},{"title3":"Early Neuromuscular Blockade in Children with Pediatric Acute Respiratory Distress Syndrome"},{"title3":"Neuromuscular manifestations of critical illness"},{"title3":"Prospective documentation of sedative, analgesic, and neuromuscular blocking agent use in infants and children in the intensive care unit: a multicenter perspective"},{"title3":"Continuous-infusion neuromuscular blocking agents in critically ill neonates and children"},{"title3":"Allergic risk during paediatric anaesthesia"},{"title3":"ICU-Acquired Weakness Is Associated With Differences in Clinical Outcomes in Critically Ill Children"},{"title3":"Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference"},{"title3":"The COMFORT behaviour scale detects clinically meaningful effects of analgesic and sedative treatment"},{"title3":"Nonrespiratory pediatric logistic organ dysfunction-2 score is a good predictor of mortality in children with acute respiratory failure"},{"title3":"Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria"},{"title3":"Reproducibility of childhood respiratory symptom questions"},{"title3":"Performance of commonly used respiratory questionnaire items in a cohort of infants born preterm"},{"title3":"Diagnosis and management of critical illness polyneuropathy and critical illness myopathy"},{"title3":"An Evaluation of Various Ventilator-Associated Infection Criteria in a PICU"},{"title3":"Consensus statement for inert gas washout measurement using multiple- and single- breath tests"},{"title3":"Reappraisal of Ventilator-Free Days in Critical Care Research"},{"title3":"Relationship between the functional status scale and the pediatric overall performance category and pediatric cerebral performance category scales"},{"title3":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support"},{"title3":"The REDCap consortium: Building an international community of software platform partners"},{"title3":"How safe is non-bronchoscopic bronchoalveolar lavage in critically ill mechanically ventilated children?"},{"title3":"Nonpulmonary Treatments for Pediatric Acute Respiratory Distress Syndrome: Proceedings From the Pediatric Acute Lung Injury Consensus Conference"},{"title3":"Functional Status Scale: new pediatric outcome measure"},{"title3":"Relevant Outcomes in Pediatric Acute Respiratory Distress Syndrome Studies"},{"title3":"Pediatric origins of adult lung disease. 1. The contribution of airway development to paediatric and adult lung disease"},{"title3":"Childhood respiratory illness and lung function at ages 14 and 50 years: childhood respiratory illness and lung function"},{"title3":"Early life origins of chronic obstructive pulmonary disease"},{"title3":"Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study"},{"title3":"Reduced PICU respiratory admissions during COVID-19"},{"title3":"Unplanned and medical admissions to pediatric intensive care units significantly decreased during COVID-19 outbreak in Northern Italy"}]},{"title2":"Prone positioning in severe acute respiratory distress syndrome.","References":[]},{"title2":"Bacterial coinfection in influenza: a grand rounds review.","References":[]},{"title2":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.","References":[{"title3":"multi-country outbreak:update 34"},{"title3":"SARS coronavirus sequencing"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Atypical pneumonia"},{"title3":"Guideline on management of severe acute respiratory syndrome (SARS)"},{"title3":"HA guidelines on severe acute respiratory syndrome"},{"title3":"The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus acute respiratory distress syndrome"},{"title3":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Radiological appearances of cytomegalovirus infections"},{"title3":"A case of influenza bronchiolitis complicated by pneumomediastinum and subcutaneous emphysema"}]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients.","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome.","References":[]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis.","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.","References":[]},{"title2":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care.","References":[]},{"title2":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.","References":[{"title3":"Definitive care for the critically ill during a disaster: current capabilities and limitations: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Refining surge capacity: conventional, contingency, and crisis capacity"},{"title3":"European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster. Chapter 2. Surge capacity and infrastructure considerations for mass critical care. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster"},{"title3":"Health care facility and community strategies for patient care surge capacity"},{"title3":"Task Force for Mass Critical Care. Summary of suggestions from the Task Force for Mass Critical Care summit, January 26-27, 2007"},{"title3":"Altevogt BM, Institute of Medicine. (U.S.). Committee on Guidance for Establishing Standards of Care for Use in Disaster Situations. Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations: A Letter Report. Washington, DC: National Academies Press; 2009."},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: a framework for allocation of scarce resources in mass critical care: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: medical resources for surge capacity: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: a framework for optimizing critical care surge capacity: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Survey about responsiveness of third-level hospitals to a medical disaster: after the pandemic influenza in Mexico [in Spanish]"},{"title3":"H1N1 influenza: critical care aspects"},{"title3":"Hospital Civil de Guadalajara, Fray Antonio Alcalde Emerging Respiratory Infections Response Team. Hospital triage system for adult patients using an influenza-like illness scoring system during the 2009 pandemic:Mexico"},{"title3":"Preparing your intensive care unit for the second wave of H1N1 and future surges"},{"title3":"Planning for a pandemic: a view from the accident and emergency department"},{"title3":"Preparing for the sickest patients with 2009 influenza A(H1N1)"},{"title3":"Influenza A(H1N1) epidemic in Argentina. Experience in a National General Hospital (Hospital Nacional Profesor Alejandro Posadas) [in Spanish]"},{"title3":"Death toll climbs and healthcare needs escalate in Japan"},{"title3":"Boston's first-in-class first response"},{"title3":"The Boston Marathon response: why did it work so well?"},{"title3":"Emergency preparedness and public health: the lessons of Hurricane Sandy"},{"title3":"Hurricane Sandy and the greater New York health care system"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Chemical weapons. U.N. taps special labs to investigate Syrian attack"},{"title3":"Lack of atropine in Syria hampers treatment after gas attacks [published correction appears in BMJ. 2013;347:f 5530]"},{"title3":"As Syria crisis mounts, scientist looks back at last major chemical attack"},{"title3":"on behalf of the Task Force for Mass Critical Care. Methodology: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement"},{"title3":"Barbera JA, Macintyre AG. Medical and Health Incident Management (MaHIM) System: A Comprehensive Functional System Description for Mass Casualty Medical and Health Incident Management. Washington, DC: Institute for Crisis, Disaster, and Risk Management, George Washington University; 2002"},{"title3":"Barbera JA, Macintyre AG. Medical Surge Capacity and Capability: A Management System for Integrating Medical and Health Resources During Large-Scale Emergencies. Washington, DC: US Department of Health and Human Services; 2004"},{"title3":"Clinical research ethics for critically ill patients: a pandemic proposal"},{"title3":"InFACT: a global critical care research response to H1N1"},{"title3":"PREEDICCT Study Group. Critical care resource allocation: trying to PREEDICCT outcomes without a crystal ball"}]}]},{"title1":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title2":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle","References":[{"title3":"XINHUANET News Report"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Coronaviruses-drug discovery and therapeutic options"},{"title3":"Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"}]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China","References":[{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Pneumonia in China: lack of information raises concerns among Hong Kong health workers"},{"title3":"Taking forward a' One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential"},{"title3":"ProMED &quot;Novel coronavirus - China (01): (HU) WHO, phylogenetic tree&quot;. Archive Number: 20200112.6885385. Accessed 13 Jan 2020. https://www.ecohealthalliance.org/2020/01/phylogenetic-analysis-shows-novel-wuhan-coronavirus-clusters-with-sars."}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance","References":[]},{"title2":"MERS, SARS and other coronaviruses as causes of pneumonia","References":[{"title3":"Coronavirus pathogenesis"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"  . Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fact Sheet [Accessed 28 Aug 2017.] Available from URL: http://www.who.int/mediacentre/factsheets/mers-cov/en/."},{"title3":"Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Evidence supporting a zoonotic origin of human coronavirus strain NL63"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Middle East Respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 Outbreak in Korea"},{"title3":"Infectivity of an asymptomatic patient with Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical features and molecular epidemiology of coronavirus-HKU1-associated community-acquired pneumonia"},{"title3":"Severe acute respiratory syndrome (SARS): a year in review"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014"},{"title3":"Outbreaks of Middle East respiratory syndrome in two hospitals initiated by a single patient in Daejeon, South Korea"},{"title3":"First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Coronavirus HKU1 and other coronavirus infections in Hong Kong"},{"title3":"Epidemiology of coronavirus-associated respiratory tract infections and the role of rapid diagnostic tests: a prospective study"},{"title3":"Prevalence and molecular epidemiology of human coronavirus HKU1 in patients with acute respiratory illness"},{"title3":"Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation"},{"title3":"Community-acquired pneumonia requiring hospitalization among U.S. adults"},{"title3":"Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China"},{"title3":"Coronavirus spike proteins in viral entry and pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the Middle East respiratory syndrome"},{"title3":"Differential expression of the Middle East respiratory syndrome coronavirus receptor in the upper respiratory tracts of humans and dromedary camels"},{"title3":"The multifunctional or moonlighting protein CD26/DPPIV"},{"title3":"Human aminopeptidase N is a receptor for human coronavirus 229E"},{"title3":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation"},{"title3":"Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"SARS-associated coronavirus replication in cell lines"},{"title3":"  . Clinical Management of Severe Acute Respiratory Infection When Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection Is Suspected [Accessed 28 Aug 2017.] Available from URl: http://www.who.int/csr/disease/coronavirus_infections/case-management-ipc/en."},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic"},{"title3":"SARS: prognosis, outcome and sequelae"},{"title3":"Clinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV-infected and HIV-uninfected South African children"},{"title3":"A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection"},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"mRNA cap-1 methyltransferase in the SARS genome"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Passive transfer of a germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal Middle East respiratory syndrome coronavirus infection"},{"title3":"Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus"},{"title3":"Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score","References":[]},{"title2":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus","References":[{"title3":"Severe acute respiratory syndrome"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Prevalence and genetic diversity of coronaviruses in bats from China"},{"title3":"Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans"},{"title3":"Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China"},{"title3":"Deciphering the bat virome catalog to better understand the ecological diversity of bat viruses and the bat origin of emerging infectious diseases"},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Isolation and Characterization of a Novel Bat Coronavirus Closely Related to the Direct Progenitor of Severe Acute Respiratory Syndrome Coronavirus"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination"},{"title3":"Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events"},{"title3":"The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"Open reading frame 8a of the human severe acute respiratory syndrome coronavirus not only promotes viral replication but also induces apoptosis"},{"title3":"Novel SARS-like betacoronaviruses in bats, China, 2011"},{"title3":"ORF8-Related Genetic Evidence for Chinese Horseshoe Bats as the Source of Human Severe Acute Respiratory Syndrome Coronavirus"},{"title3":"Amplification of emerging viruses in a bat colony"},{"title3":"Longitudinal surveillance of SARS-like coronaviruses in bats by quantitative real-time PCR"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"The 8ab protein of SARS-CoV is a luminal ER membrane-associated protein and induces the activation of ATF6"},{"title3":"Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein"},{"title3":"Bat severe acute respiratory syndrome-like coronavirus ORF3b homologues display different interferon antagonist activities"},{"title3":"Evolution of the cytochrome b gene of mammals"},{"title3":"Cryptic diversity in European bats"},{"title3":"Building phylogenetic trees from molecular data with MEGA"},{"title3":"RDP3: a flexible and fast computer program for analyzing recombination"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0"}]},{"title2":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human","References":[]},{"title2":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation","References":[]},{"title2":"Evidence for camel-to-human transmission of MERS coronavirus","References":[]},{"title2":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history","References":[]},{"title2":"Origin and evolution of pathogenic coronaviruses","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Severe Acute Respiratory Syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"SARS-CoV-2 and COVID-19: the most important research questions"},{"title3":"New insights into the mechanisms of RNA recombination"},{"title3":"Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure"},{"title3":"RNA recombination in animal and plant viruses"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Adaptive evolution of MERS-CoV to species variation in DPP4"},{"title3":"Bats and coronaviruses"}]},{"title2":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin","References":[{"title3":"Host and viral traits predict zoonotic spillover from mammals"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China"},{"title3":"Isolation and characterization of a novel bat coronavirus closely related to the direct progenitor of severe acute respiratory syndrome coronavirus"},{"title3":"ORF8-related genetic evidence for Chinese horseshoe bats as the source of human severe acute respiratory syndrome coronavirus"},{"title3":"Discovery and genetic analysis of novel coronaviruses in least horseshoe bats in southwestern China"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Porcine deltacoronavirus in mainland China"},{"title3":"Epidemiology and vaccine of porcine epidemic diarrhea virus in China: a mini-review"},{"title3":"Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome"},{"title3":"Molecular epidemiology of porcine epidemic diarrhea virus in China"},{"title3":"Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay"},{"title3":"A new bat-HKU2-like coronavirus in swine, China, 2017"},{"title3":"Discovery of a novel swine enteric alphacoronavirus (SeACoV) in southern China"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Masters, P. S. &amp; Perlman, S. in Fields Virology Vol. 2 (eds Knipe, D. M. &amp; Howley, P. M.) 825-858 (Lippincott Williams &amp; Wilkins, Philadelphia, 2013)."},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"}]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission","References":[{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"SWISSMODEL: an automated protein homology-modeling server"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"}]},{"title2":"Wuhan coronavirus has strong ability to infect humans. Press release","References":[]},{"title2":"From SARS to MERS, thrusting coronaviruses into the spotlight","References":[{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"SARS and MERS: Recent insights into emerging coronaviruses"},{"title3":"WHO Guidelines for the Global Surveillance of Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: A serologic, epidemiologic, and clinical description"},{"title3":"Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013-2014"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014"},{"title3":"Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015"},{"title3":"Severe acute respiratory syndrome (SARS): A year in review"},{"title3":"Coronaviruses: An overview of their replication and pathogenesis"},{"title3":"Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models"},{"title3":"MERS-CoV spike protein: A key target for antivirals"},{"title3":"The spike protein of SARS-CoV:A target for vaccine and therapeutic development"},{"title3":"Middle East respiratory syndrome"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"The life cycle of SARS coronavirus in Vero E6 cells"},{"title3":"Pathogenetic mechanisms of severe acute respiratory syndrome"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways"},{"title3":"Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome"},{"title3":"Differential Expression of the Middle East Respiratory Syndrome Coronavirus Receptor in the Upper Respiratory Tracts of Humans and Dromedary Camels"},{"title3":"2014 MERS-CoV outbreak in Jeddah:A link to health care facilities"},{"title3":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: Implications for pathogenesis"},{"title3":"Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways"},{"title3":"MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2"},{"title3":"Protective T Cell Res.ponses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC"},{"title3":"Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Receptor recognition mechanisms of coronaviruses: A decade of structural studies"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Current advancements and potential strategies in the development of MERS-CoV vaccines"},{"title3":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus"},{"title3":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor"},{"title3":"Core structure of S2 from the human coronavirus NL63 spike glycoprotein"},{"title3":"Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core"},{"title3":"Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core"},{"title3":"S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients"},{"title3":"SARS-associated coronavirus"},{"title3":"Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"The SARS-CoV S glycoprotein: Expression and functional characterization"},{"title3":"A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2"},{"title3":"A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity"},{"title3":"Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry"},{"title3":"A decade after SARS: Strategies for controlling emerging coronaviruses"},{"title3":"Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: Implications for the development of vaccines and antiviral agents"},{"title3":"An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies"},{"title3":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS"},{"title3":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice"},{"title3":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro"},{"title3":"Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets"},{"title3":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets"},{"title3":"Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants"},{"title3":"Evaluation of candidate vaccine approaches for MERS-CoV"},{"title3":"Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology"},{"title3":"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice"},{"title3":"DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice"},{"title3":"Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein"},{"title3":"MERS-CoV vaccine candidates in development: The current landscape"},{"title3":"Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses"},{"title3":"SARS vaccines: Where are we?"},{"title3":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine"},{"title3":"Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus"},{"title3":"Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus"},{"title3":"Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease"},{"title3":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge"},{"title3":"Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549)"},{"title3":"Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein"},{"title3":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease"},{"title3":"Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate"},{"title3":"Engineering attenuated virus vaccines by controlling replication fidelity"},{"title3":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region"},{"title3":"Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge"},{"title3":"The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein"},{"title3":"SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus"},{"title3":"The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization"},{"title3":"SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens"},{"title3":"Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection"},{"title3":"Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library"},{"title3":"Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides"},{"title3":"Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein"},{"title3":"Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion"},{"title3":"Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: Implication for vaccine design"},{"title3":"Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein"},{"title3":"Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: Importance for designing SARS vaccines"},{"title3":"Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)"},{"title3":"Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"An efficient method to make human monoclonal antibodies from memory B cells: Potent neutralization of SARS coronavirus"},{"title3":"Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge"},{"title3":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies"},{"title3":"Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse"},{"title3":"Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus"},{"title3":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association"},{"title3":"Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: Implications for virus fusogenic mechanism and identification of fusion inhibitors"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein"},{"title3":"Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus"},{"title3":"Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)"},{"title3":"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies"},{"title3":"Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-possible lessons from a systematic review of SARS-CoV therapy"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants"},{"title3":"A serological survey on neutralizing antibody titer of SARS convalescent sera"},{"title3":"Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS Model"},{"title3":"Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates"},{"title3":"Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset"},{"title3":"SARS: Systematic Review of Treatment Effects"},{"title3":"SARS: Clinical presentation, transmission, pathogenesis and treatment options"},{"title3":"Treatment with Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice"},{"title3":"Mice susceptible to SARS coronavirus"},{"title3":"Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice"},{"title3":"Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1"},{"title3":"Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Evasion by stealth: Inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection"},{"title3":"A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses"},{"title3":"Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice"},{"title3":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine"},{"title3":"SARS vaccine protective in mice"},{"title3":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice"},{"title3":"An immunosuppressed Syrian golden hamster model for SARS-CoV infection"},{"title3":"Protection from infection with severe acute respiratory syndrome coronavirus in a Chinese hamster model by equine neutralizing F(ab')2"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters"},{"title3":"Virology: SARS virus infection of cats and ferrets"},{"title3":"Pathology of experimental SARS coronavirus infection in cats and ferrets"},{"title3":"Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets"},{"title3":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets"},{"title3":"Severe acute respiratory syndrome vaccine efficacy in ferrets: Whole killed virus and adenovirus-vectored vaccines"},{"title3":"An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"Macaque model for severe acute respiratory syndrome"},{"title3":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque"},{"title3":"Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Cynomolgus macaque as an animal model for severe acute respiratory syndrome"},{"title3":"Animal models for SARS"},{"title3":"Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques"},{"title3":"Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection"},{"title3":"Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus"},{"title3":"Domestic Pig Unlikely Reservoir for MERS-CoV"},{"title3":"Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters"},{"title3":"Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice"},{"title3":"Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels"},{"title3":"Infection, Replication, and Transmission of Middle East Respiratory Syndrome Coronavirus in Alpacas"},{"title3":"Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus"},{"title3":"An Animal Model of MERS Produced by Infection of Rhesus Macaques with MERS Coronavirus"},{"title3":"Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates"},{"title3":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection"},{"title3":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4"}]},{"title2":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","References":[]},{"title2":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Severe acute respiratory syndrome"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"The Pathology and Pathogenesis of Experimental Severe Acute Respiratory Syndrome and Influenza in Animal Models"},{"title3":"The Immunobiology of SARS*"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"SARS in Singapore--predictors of disease severity"},{"title3":"The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health"},{"title3":"Sex differences in immune responses"},{"title3":"Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity"},{"title3":"Sex-associated hormones and immunity to protozoan parasites"},{"title3":"Role of sex steroid hormones in bacterial-host interactions"},{"title3":"Sex hormones and the immune response in humans"},{"title3":"Sex differences in the recognition of and innate antiviral responses to Seoul virus in Norway rats"},{"title3":"Elevated 17beta-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses"},{"title3":"17beta-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs"},{"title3":"CD200 receptor controls sex-specific TLR7 responses to viral infection"},{"title3":"Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis"},{"title3":"The complex role of estrogens in inflammation"},{"title3":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men"},{"title3":"Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors"},{"title3":"Type I interferon is a therapeutic target for virus-induced lethal vascular damage"},{"title3":"Tamoxifen administration to mice"},{"title3":"Age-dependent dysregulation of innate immunity"},{"title3":"Implications of X-linked gene regulation for sex differences in disease pathogenesis (comment on DOI 10.1002/bies.201100047)"},{"title3":"The effects of hormones on sex differences in infection: from genes to behavior"},{"title3":"Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox"},{"title3":"Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1"},{"title3":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha signaling"},{"title3":"Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages"},{"title3":"Estrogen inhibits lipopolysaccharide-induced tumor necrosis factor-alpha release from murine macrophages"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice"},{"title3":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8"}]},{"title2":"Sexual dimorphism in innate immunity","References":[{"title3":"Overview of the immune response"},{"title3":"Genetic influence on inflammation variables in the elderly"},{"title3":"C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci"},{"title3":"Trained immunity: A program of innate immune memory in health and disease"},{"title3":"Defining trained immunity and its role in health and disease"},{"title3":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes"},{"title3":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes"},{"title3":"Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity"},{"title3":"Metabolic Induction of Trained Immunity through the Mevalonate Pathway"},{"title3":"Heme induces innate immune memory"},{"title3":"Host and Environmental Factors Influencing Individual Human Cytokine Responses"},{"title3":"Sex-differences in the prevalence of Helicobacter pylori infection in pediatric and adult populations: Systematic review and meta-analysis of 244 studies"},{"title3":"Sexual inequality in tuberculosis"},{"title3":"Gender disparity in infections of Hepatitis B virus"},{"title3":"Sexual Dimorphism in Innate Immunity"},{"title3":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients"},{"title3":"The Xs and Y of immune responses to viral vaccines"},{"title3":"An immune clock of human pregnancy"},{"title3":"Trained Memory of Human Uterine NK Cells Enhances Their Function in Subsequent Pregnancies"},{"title3":"Sex hormones and the immune response in humans"},{"title3":"Signaling by nuclear receptors"},{"title3":"Rapid steroid hormone actions via membrane receptors"},{"title3":"Sex steroid receptors in immune cells"},{"title3":"Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations"},{"title3":"X-chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-alpha production of plasmacytoid dendritic cells from women"},{"title3":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha signaling"},{"title3":"Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling"},{"title3":"Estrogen receptors regulate innate immune cells and signaling pathways"},{"title3":"The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases"},{"title3":"Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity"},{"title3":"The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway"},{"title3":"Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo"},{"title3":"CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor"},{"title3":"Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERalpha36 and GPR30/GPER1"},{"title3":"NF-kappaB signaling in inflammation"},{"title3":"Nuclear Factor-kappaB in Autoimmunity: Man and Mouse"},{"title3":"The potential influence of breast cancer estrogen receptors' distribution on active DNA demethylation"},{"title3":"Membrane progesterone receptor beta (mPRbeta/Paqr8) promotes progesterone-dependent neurite outgrowth in PC12 neuronal cells via non-G protein-coupled receptor (GPCR) signaling"},{"title3":"Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis"},{"title3":"Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites"},{"title3":"Inhibitory effects of progesterone differ in dendritic cells from female and male rodents"},{"title3":"Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis"},{"title3":"Differential Modulation of TLR3- and TLR4-Mediated Dendritic Cell Maturation and Function by Progesterone"},{"title3":"Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors"},{"title3":"Androgen Receptor Structure, Function and Biology: From Bench to Bedside"},{"title3":"Androgen-Induced Immunosuppression"},{"title3":"Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes"},{"title3":"[17beta-Estradiol and testosterone influence the mRNA expression and the time course of inflammatory cytokines in activated human monocytic cell line (THP-1)]"},{"title3":"Testosterone Reduces Macrophage Expression in the Mouse of Toll-Like Receptor 4, a Trigger for Inflammation and Innate Immunity"},{"title3":"The effect of testosterone on cytokine production in the specific and non-specific immune response"},{"title3":"The impact of sex hormones on BCG-induced trained immunity"},{"title3":"The role of circulating sex hormones in menstrual cycle-dependent modulation of pain-related brain activation"},{"title3":"The complex role of estrogens in inflammation"},{"title3":"Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages"},{"title3":"Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity"},{"title3":"The inducible expression of THP-1 cell interleukin-1 mRNA: Effects of estrogen on differential response to phorbol ester and lipopolysaccharide"},{"title3":"Neutrophil extracellular traps: double-edged swords of innate immunity"},{"title3":"Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone"},{"title3":"Estrogen Modulates Inflammatory Mediator Expression and Neutrophil Chemotaxis in Injured Arteries"},{"title3":"Estrogens Augment Cell Surface TLR4 Expression on Murine Macrophages and Regulate Sepsis Susceptibility in Vivo"},{"title3":"Sexual dimorphism in bacterial infections"},{"title3":"Association of Sex With Clinical Outcome in Critically Ill Sepsis Patients: A Retrospective Analysis of the Large Clinical Database MIMIC-III"},{"title3":"Progesterone-Related Immune Modulation of Pregnancy and Labor"},{"title3":"Multimodal Regulation of NET Formation in Pregnancy: Progesterone Antagonizes the Pro-NETotic Effect of Estrogen and G-CSF"},{"title3":"Selective inhibition and augmentation of alternative macrophage activation by progesterone"},{"title3":"Progesterone rapidly down-regulates the biosynthesis of 5-lipoxygenase products in human primary monocytes"},{"title3":"The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review"},{"title3":"Chapter 11 - Role of Macrophages in Autoimmunity"},{"title3":"Sexual dimorphism in autoimmunity"},{"title3":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States"},{"title3":"Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan"},{"title3":"How does age at onset influence the outcome of autoimmune diseases"},{"title3":"Autoimmune diseases and reproductive aging"},{"title3":"Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice"},{"title3":"Suppression of the inflammatory response in experimental arthritis is mediated via estrogen receptor alpha but not estrogen receptor beta"},{"title3":"Treatment with an Estrogen Receptor alpha Ligand Is Neuroprotective in Experimental Autoimmune Encephalomyelitis"},{"title3":"The Anti-Inflammatory Effects of Testosterone"},{"title3":"Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice"},{"title3":"Effect of Castration on the Appearance of Diabetes in NOD Mouse"},{"title3":"A Protective Role For Testosterone In Adjuvant-Induced Arthritis"},{"title3":"Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells"},{"title3":"Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus"},{"title3":"Prolonged hypogonadism in male patients with rheumatoid arthritis during flares in disease activity"},{"title3":"Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation"},{"title3":"Free and serum testosterone levels in 276 males: a comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls"},{"title3":"Decreased testosterone levels in men with rheumatoid arthritis: effect of low dose prednisone therapy"},{"title3":"Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems"},{"title3":"Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation"},{"title3":"Gonadal hormones in men with rheumatoid arthritis-from onset through 2 years"},{"title3":"Bioavailable testosterone in men with rheumatoid arthritis-high frequency of hypogonadism"},{"title3":"High frequency of association of rheumatic/autoimmune diseases and untreated male hypogonadism with severe testicular dysfunction"},{"title3":"Systemic lupus erythematosus in men. Genetic and endocrine features"},{"title3":"Abnormalities of sex hormones in men with systemic lupus erythematosus"},{"title3":"Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus"},{"title3":"Systemic lupus erythematosus: sex hormones in male patients"},{"title3":"Evaluation of the hypothalamic-pituitary-gonadal axis in males with systemic lupus erythematosus"},{"title3":"Hormonal profiles and immunological studies of male lupus in Taiwan"},{"title3":"Profile of sex hormones in male patients with systemic lupus erythematosus"},{"title3":"Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus"},{"title3":"Penile anthropometry in systemic lupus erythematosus patients"},{"title3":"The neuroendocrine axis in patients with multiple sclerosis"},{"title3":"Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis"},{"title3":"Hypogonadism and the risk of rheumatic autoimmune disease"},{"title3":"A Higher Ratio of Estradiol to Testosterone Is Associated with Autoimmune Thyroid Disease in Males"},{"title3":"The relationship between circulating estradiol and thyroid autoimmunity in males"},{"title3":"Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival"},{"title3":"Sex Differences in the Blood Transcriptome Identify Robust Changes in Immune Cell Proportions with Aging and Influenza Infection"},{"title3":"Sex differences in the human peripheral blood transcriptome"},{"title3":"ImmGen report: sexual dimorphism in the immune system transcriptome"},{"title3":"Integrative analysis of methylome and transcriptome in human blood identifies extensive sex-and immune cell-specific differentially methylated regions"},{"title3":"Adaptation and memory in immune responses"},{"title3":"Perceptions of epigenetics"},{"title3":"Latent enhancers activated by stimulation in differentiated cells"},{"title3":"Transcriptional and epigenetic regulation of macrophages in atherosclerosis"},{"title3":"beta-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance"},{"title3":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity"},{"title3":"Human monocyte-to-macrophage differentiation involves highly localized gain and loss of DNA methylation at transcription factor binding sites"},{"title3":"Extensive epigenomic integration of the glucocorticoid response in primary human monocytes and in vitro derived macrophages"},{"title3":"Epigenetics of estrogen receptor signaling: role in hormonal cancer progression and therapy"},{"title3":"Steroid hormones regulate genome-wide epigenetic programming and gene transcription in human endometrial cells with marked aberrancies in endometriosis"},{"title3":"Global DNA methylation changes spanning puberty are near predicted estrogen-responsive genes and enriched for genes involved in endocrine and immune processes"},{"title3":"Pubertal development in healthy children is mirrored by DNA methylation patterns in peripheral blood"},{"title3":"DNA Methylation Trajectories During Pregnancy"},{"title3":"The Cellular Transcriptome in the Maternal Circulation During Normal Pregnancy: A Longitudinal Study"},{"title3":"Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy"},{"title3":"Transient epigenomic changes during pregnancy and early postpartum in women with and without type 2 diabetes"},{"title3":"Effect of Menopause on Gene Expression Profiles of Circulating Monocytes: A Pilot in vivo Microarray Study"},{"title3":"Hormone Replacement Therapy Associated White Blood Cell DNA Methylation and Gene Expression are Associated With Within-Pair Differences of Body Adiposity and Bone Mass"},{"title3":"Effects of Ageing on the Immune System: Infants to Elderly"},{"title3":"T-cell subsets in healthy teenagers: Transition to the adult phenotype"},{"title3":"Immune Function in Healthy Adolescents"},{"title3":"Hormones in pregnancy"},{"title3":"Human Chorionic Gonadotropin as a Pivotal Endocrine Immune Regulator Initiating and Preserving Fetal Tolerance"},{"title3":"Mechanism of human chorionic gonadotrophin-mediated immunomodulation in pregnancy"},{"title3":"Shifts in the TH1/TH2 Balance during Human Pregnancy Correlate with Apoptotic Changes"},{"title3":"The Th1:th2 dichotomy of pregnancy and preterm labour"},{"title3":"Modulations of Cytokine Expression in Pregnant Women"},{"title3":"The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions"},{"title3":"Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions"},{"title3":"Pregnancy-specific down-regulation of NF-kappa B expression in T cells in humans is essential for the maintenance of the cytokine profile required for pregnancy success"},{"title3":"The pro-inflammatory and anti-inflammatory cytokine profile in peripheral blood of women with recurrent implantation failure"},{"title3":"Regulatory T cells mediate maternal tolerance to the fetus"},{"title3":"Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset"},{"title3":"Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice"},{"title3":"Influence of reproductive hormones on the induction of CD4(+)CD25 (bright)Foxp (3+) regulatory T cells"},{"title3":"Immune Modulatory Effects of Human Chorionic Gonadotropin on Dendritic Cells Supporting Fetal Survival in Murine Pregnancy"},{"title3":"Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy"},{"title3":"Human Chorionic Gonadotropin modulates CXCL10 Expression through Histone Methylation in human decidua"},{"title3":"The contribution of macrophages to normal and pathological pregnancies"},{"title3":"Gene Expression Profiling of Human Decidual Macrophages: Evidence for Immunosuppressive Phenotype"},{"title3":"In-depth characterization of monocyte subsets during the course of healthy pregnancy"},{"title3":"Innate immune responses to toll-like receptor stimulation are altered during the course of pregnancy"},{"title3":"Endotoxin-induced cytokine production of monocytes of third-trimester pregnant women compared with women in the follicular phase of the menstrual cycle"},{"title3":"The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro"},{"title3":"Estrogen-dependent regulation of human uterine natural killer cells promotes vascular remodelling via secretion of CCL2"},{"title3":"The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection"},{"title3":"Progesterone Enhances Interleukin-15 Production in Human Endometrial Stromal Cells in Vitro1"},{"title3":"The remission of rheumatoid arthritis during pregnancy"},{"title3":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group"},{"title3":"Immunity, thyroid function and pregnancy: molecular mechanisms"},{"title3":"How pregnancy can affect autoimmune diseases progression"},{"title3":"Obstetric outcome in systemic lupus erythematosus"},{"title3":"Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies"},{"title3":"Estradiol-17beta-Induced Changes in the Porcine Endometrial Transcriptome In Vivo"},{"title3":"The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study"},{"title3":"Reproductive hormones and the menopause transition"},{"title3":"Effects of Sex Hormones and Age on Brain Volume in Post-Menopausal Women"},{"title3":"Hormone replacement therapy and the prevention of postmenopausal osteoporosis"},{"title3":"Global gene expression profiles in skeletal muscle of monozygotic female twins discordant for hormone replacement therapy"},{"title3":"Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women"},{"title3":"Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women"},{"title3":"The relationship between testosterone and molecular markers of inflammation in older men"},{"title3":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases"},{"title3":"Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination"},{"title3":"Hormone therapy for trans and gender diverse patients in the general practice setting"},{"title3":"Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study"},{"title3":"What does the &quot;four core genotypes&quot; mouse model tell us about sex differences in the brain and other tissues"},{"title3":"A primer on the use of mouse models for identifying direct sex chromosome effects that cause sex differences in non-gonadal tissues"},{"title3":"The number of x chromosomes causes sex differences in adiposity in mice"},{"title3":"Sex differences in diurnal rhythms of food intake in mice caused by gonadal hormones and complement of sex chromosomes"},{"title3":"Significant symptomatic improvement of subacute cutaneous lupus after testosterone therapy in a female-to-male transgender subject"},{"title3":"Lupus erythematosus tumidus induced by sex reassignment surgery"},{"title3":"Development of systemic lupus erythematosus in a male-to-female transsexual: the role of sex hormones revisited"},{"title3":"New-onset lupus nephritis after male-to-female sex reassignment surgery"},{"title3":"Effects of sex steroids on the pattern of methylation and expression of the promoter region of estrogen and androgen receptors in people with gender dysphoria under cross-sex hormone treatment"},{"title3":"Transgender Women on Feminizing Hormone Therapy Demonstrate a Distinct Rectal Mucosal Transcriptome from Cisgender Men"},{"title3":"BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner"},{"title3":"Personalized vaccinology: one size and dose might not fit both sexes"}]},{"title2":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections","References":[]},{"title2":"Clinical findings in 111 cases of influenza A (H7N9) virus infection","References":[]},{"title2":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai","References":[{"title3":"Human infection with a novel avian-origin influenza A (H7N9) virus. N human infection with a novel avian-origin influenza A (H7N9) virus"},{"title3":"Influenza viruses: from birds to humans"},{"title3":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome"},{"title3":"Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013"},{"title3":"Family outbreak of severe pneumonia induced by H7N9 infection"},{"title3":"Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome"},{"title3":"Body mass index is associated with the development of acute respiratory distress syndrome"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Determinants of antiviral effectiveness in influenza virus A subtype H5N1"},{"title3":"Risk factors for mortality in patients with nosocomial Gram-negative rod bacteremia"},{"title3":"Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome"},{"title3":"What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients?"},{"title3":"What is the role of steroids in pneumonia therapy?"},{"title3":"Clinical analysis of complications after non- invasive positive pressure ventilation and an inquiry into the respiratory treatment strategy in patients with SARS"},{"title3":"Evolution of pulmonary pathology in severe acute respiratory syndrome"}]},{"title2":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","References":[{"title3":"Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses"},{"title3":"DNA vaccination: transfection and activation of dendritic cells as key events for immunity"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Antibody response and disease severity in healthcare worker MERS survivors"},{"title3":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia"},{"title3":"High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection"},{"title3":"Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals"},{"title3":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection"},{"title3":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex"},{"title3":"Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant"},{"title3":"Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T Lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Characteristics of traveler with Middle East respiratory syndrome, China, 2015"},{"title3":"The HLA-A2-supermotif: a QSAR definition"},{"title3":"The spike protein of SARS-CoV-a target for vaccine and therapeutic development"},{"title3":"Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC"},{"title3":"Vaccines for the prevention against the threat of MERS-CoV"},{"title3":"A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity"},{"title3":"Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells"},{"title3":"Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection"},{"title3":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses"},{"title3":"Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus"},{"title3":"Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses"},{"title3":"Improved transgenic mouse model for studying HLA class I antigen presentation"},{"title3":"Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling"},{"title3":"Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA"},{"title3":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States"},{"title3":"Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen"},{"title3":"Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus"},{"title3":"Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms"},{"title3":"Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Identification of an epitope of SARS-coronavirus nucleocapsid protein"},{"title3":"Functional and structural definition of a clustering region of HLA-A2-restricted cytotoxic T lymphocyte epitopes"},{"title3":"The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes"},{"title3":"Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein"},{"title3":"Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development"},{"title3":"Characterization of human alphabetaTCR repertoire and discovery of D-D fusion in TCRbeta chains"},{"title3":"Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome"},{"title3":"Protective T-cell responses featured by concordant recognition of MERS-CoV-derived CD8+ T-cell epitopes and host MHC"},{"title3":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV"},{"title3":"Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV"},{"title3":"Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent"},{"title3":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity"},{"title3":"Serological assays for emerging coronaviruses: challenges and pitfalls"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"The structure and function of CD26 in the T-cell immune response"},{"title3":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope"},{"title3":"Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice"},{"title3":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea"},{"title3":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients"},{"title3":"Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Specific serology for emerging human coronaviruses by protein microarray"},{"title3":"Geographic distribution of MERS coronavirus among dromedary camels, Africa"},{"title3":"Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity"},{"title3":"Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A comprehensive comparison of transmembrane domains reveals organelle-specific properties"},{"title3":"Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system"},{"title3":"MERS in South Korea and China: a potential outbreak threat?"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes"},{"title3":"Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"From SARS coronavirus to novel animal and human coronaviruses"},{"title3":"Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes"},{"title3":"HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Middle East respiratory syndrome and severe acute respiratory syndrome"},{"title3":"Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein"},{"title3":"Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015"},{"title3":"Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis"},{"title3":"T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia"},{"title3":"Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein"},{"title3":"Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen"},{"title3":"Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Current advancements and potential strategies in the development of MERS-CoV vaccines"},{"title3":"Frequency, private specificity, and cross-reactivity of preexisting hepatitis C virus (HCV)-Specific CD8+ T cells in HCV-seronegative individuals: implications for vaccine responses"},{"title3":"Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8(+) T cells are augmented in varying degrees by CpG ODN, PolyI: C and R848"},{"title3":"CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein"},{"title3":"Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes"},{"title3":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"}]}]}]}